Cargando…
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504426/ https://www.ncbi.nlm.nih.gov/pubmed/34635796 http://dx.doi.org/10.1038/s41409-021-01487-4 |
| _version_ | 1784581320822751232 |
|---|---|
| author | Salvini, Marco Maggi, Fabrizio Damonte, Camilla Mortara, Lorenzo Bruno, Antonino Mora, Barbara Brociner, Marco Mattarucchi, Roberta Ingrassia, Alessia Sirocchi, Davide Bianchi, Benedetta Agnoli, Stefania Gallazzi, Matteo Merli, Michele Ferrario, Andrea Bombelli, Raffaella Barraco, Daniela Baj, Andreina Bertù, Lorenza Grossi, Paolo A. Passamonti, Francesco |
| author_facet | Salvini, Marco Maggi, Fabrizio Damonte, Camilla Mortara, Lorenzo Bruno, Antonino Mora, Barbara Brociner, Marco Mattarucchi, Roberta Ingrassia, Alessia Sirocchi, Davide Bianchi, Benedetta Agnoli, Stefania Gallazzi, Matteo Merli, Michele Ferrario, Andrea Bombelli, Raffaella Barraco, Daniela Baj, Andreina Bertù, Lorenza Grossi, Paolo A. Passamonti, Francesco |
| author_sort | Salvini, Marco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8504426 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85044262021-10-12 Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation Salvini, Marco Maggi, Fabrizio Damonte, Camilla Mortara, Lorenzo Bruno, Antonino Mora, Barbara Brociner, Marco Mattarucchi, Roberta Ingrassia, Alessia Sirocchi, Davide Bianchi, Benedetta Agnoli, Stefania Gallazzi, Matteo Merli, Michele Ferrario, Andrea Bombelli, Raffaella Barraco, Daniela Baj, Andreina Bertù, Lorenza Grossi, Paolo A. Passamonti, Francesco Bone Marrow Transplant Correspondence Nature Publishing Group UK 2021-10-11 2022 /pmc/articles/PMC8504426/ /pubmed/34635796 http://dx.doi.org/10.1038/s41409-021-01487-4 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Salvini, Marco Maggi, Fabrizio Damonte, Camilla Mortara, Lorenzo Bruno, Antonino Mora, Barbara Brociner, Marco Mattarucchi, Roberta Ingrassia, Alessia Sirocchi, Davide Bianchi, Benedetta Agnoli, Stefania Gallazzi, Matteo Merli, Michele Ferrario, Andrea Bombelli, Raffaella Barraco, Daniela Baj, Andreina Bertù, Lorenza Grossi, Paolo A. Passamonti, Francesco Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation |
| title | Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation |
| title_full | Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation |
| title_fullStr | Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation |
| title_full_unstemmed | Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation |
| title_short | Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation |
| title_sort | immunogenicity of anti-sars-cov-2 comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504426/ https://www.ncbi.nlm.nih.gov/pubmed/34635796 http://dx.doi.org/10.1038/s41409-021-01487-4 |
| work_keys_str_mv | AT salvinimarco immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT maggifabrizio immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT damontecamilla immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT mortaralorenzo immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT brunoantonino immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT morabarbara immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT brocinermarco immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT mattarucchiroberta immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT ingrassiaalessia immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT sirocchidavide immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT bianchibenedetta immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT agnolistefania immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT gallazzimatteo immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT merlimichele immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT ferrarioandrea immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT bombelliraffaella immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT barracodaniela immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT bajandreina immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT bertulorenza immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT grossipaoloa immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation AT passamontifrancesco immunogenicityofantisarscov2comirnatyvaccineinpatientswithlymphomasandmyelomawhounderwentautologousstemcelltransplantation |